RSS   Newsletter   Contact   Advertise with us

Vystar buys assets of UV Flu Technologies to kill 99% of airborne bacteria

Share on Twitter Share on LinkedIn
Staff Writer | May 11, 2018
Vystar Corporation has acquired substantially all of the assets of UV Flu Technologies, formerly traded on the OTC under the ticker UVFT.
Vystar Corporation
Acquisition   Airborne viruses that cause influenza
UV Flu Technologies's patented ViraTech UV light air purification technology destroys greater than 99% of airborne bacteria, viruses and other microorganisms and virtually eliminates concentrations of odors and volatile organic compounds (VOCs).

UV Flu products use 48 inches of high-intensity germicidal UV lamps that destroy bacteria, viruses and other germs instead of just trapping them, setting it apart from ordinary air filtration units.

RxAir is one of the few UV air purifiers that have been proven in independent EPA- and FDA-certified testing laboratories to destroy on the first pass 99.6% of harmful airborne viruses and bacteria.

In addition to inactivating airborne viruses that cause influenza (flu) and colds, RxAir’s device disarms the airborne pathogens that cause MRSA (staph), strep (whooping cough), tuberculosis (TB), measles, pneumonia and a myriad of other antibiotic-resistant and viral infections. (see news video with RX3000 in use).


 

MORE INSIDE POST